ConductScience.org, home

Gene · 6579

Papers2,617

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Multimodal imaging techniques in Yttrium-90 radioembolization for hepatocellular carcinoma: a modality-oriented clinical review.Front Oncol202641710661PubTator, text miningPubMed
Metabolic interactions in the brain: the crucial roles of neurons, astrocytes, and microglia in health and disease.Front Neurosci202641710159PubTator, text miningPubMed
Coupled pharmacokinetic model unveils drug-drug interactions in plasma concentration.PLoS One202641666235PubTator, text miningPubMed
Expert Consensus on the Diagnosis and Management of Inherited Hyperbilirubinemia (2025).J Clin Transl Hepatol202641659992PubTator, text miningPubMed
Evaluation of in Vitro Cytotoxicity and Induction Potential of Açaí (Euterpe oleracea) Extracts in Human Hepatocytes.J Diet Suppl202641641519PubTator, text miningPubMed
The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications.Clin Transl Sci202641635062PubTator, text miningPubMed
Dicloxacillin and Flucloxacillin Inhibit Hepatic Uptake Transporters-In Vitro Investigations and Physiologically Based Pharmacokinetic Modeling.Clin Transl Sci202641630535PubTator, text miningPubMed
A conserved salt bridge network stabilizes the hepatic organic anion transporters OATP1B1 and OATP1B3.J Biol Chem202641617032PubTator, text miningPubMed
Machine learning models for drug-drug interaction prediction from computational discovery to clinical application.NPJ Digit Med202641611854PubTator, text miningPubMed
Contribution of organic anion transporting polypeptides to bile acid uptake in the Caco-2 cell monolayer and gastrointestinal tract.J Biol Chem202641581875PubTator, text miningPubMed
Gadoxetic Acid-enhanced MRI Radiomics Features of Tumor Margins for Predicting High-Risk Solitary Hepatocellular Carcinoma Aggressiveness and Prognosis.Radiol Imaging Cancer202641575341PubTator, text miningPubMed
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications.
Curr Ther Res Clin Exp202641567854PubTator, text miningPubMed
A novel molecular classifier enabling identification and prediction on immunotherapeutic response for MYCN-low pediatric neuroblastoma.Cell Oncol (Dordr)202641553393PubTator, text miningPubMed
The potential of deep learning on the discovery of new genes implicated in differences of sex development.Comput Struct Biotechnol J202641550136PubTator, text miningPubMed
Development of a Physiologically Based Model of Bilirubin Metabolism in Health and Disease and Its Comparison With Real-World Data.CPT Pharmacometrics Syst Pharmacol202641543361PubTator, text miningPubMed
Hepatic organic anion transporting polypeptides (OATPs) as MRI reporter proteins.Npj Imaging202641501234PubTator, text miningPubMed
Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance.Drug Metab Pharmacokinet202641494463PubTator, text miningPubMed
A pharmacokinetics study to evaluate drug-drug interactions between fipaxalparant and concomitant medications in healthy participants.Clin Pharmacol Drug Dev202641253600PubTator, text miningPubMed
Clinical assessment of mocravimod as a victim of drug-drug interactions via CYP3A4 metabolism and transporters.Clin Pharmacol Drug Dev202641159960PubTator, text miningPubMed
Insights into Transport Function of the Murine Organic Anion-Transporting Polypeptide OATP1B2 by Comparison with Its Rat and Human Orthologues.Toxics202541600559PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6579/papers?page=3